(Regeneron-1787) Cemiplimab in CSCC or BCC

What is the Purpose of this Study?

If you choose to be in this study, you will:
-Get injected with the study drug (Cemiplimab) for 12 weeks
-Have a Blood draw
-Get a small biopsy of the skin
-Have an x-ray of your chest
-Give a urine sample
What is the Condition Being Studied?
Recurrent Cutaneous Squamous Cell Carcinoma (a type of skin cancer that keeps returning)

Who Can Participate in this Study?

Adults with Squamous Cell Carcinoma that keeps coming back.

-The lesion must be about a half inch to one inch across

Age Group
Participating Institutions

What is Involved?

We are doing the study to understand how your body reacts to the study drug, Cemiplimab.

Study Details

Full Title
A Phase 1 Study of Pre-Operative Cemiplimab (REGN2810), Administered Intralesionally, for Patients with Recurrent Cutaneous Squamous Cell Carcinoma (CSCC) or Basal Cell Carcinoma ( BCC)
Principal Investigator

Melanoma and other Skin DCI Clinical Research Team
Protocol Number

View on ClinicalTrials.gov